publication venue for
- Discovery of ICOS-targeted small molecules using pharmacophore-based screening. 2023
- Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer. 2023
- Development of Isatin-Based Schiff Bases Targeting VEGFR-2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies.. 17. 2022
- Discovery of a Histidine-Based Scaffold as an Inhibitor of Gut Microbial Choline Trimethylamine-Lyase.. 15. 2020
- Designing Dual Transglutaminase 2/Histone Deacetylase Inhibitors Effective at Halting Neuronal Death.. 13. 2018
- Development of a New Structural Class of Broadly Acting HCV Non-Nucleoside Inhibitors Leading to the Discovery of MK-8876.. 12. 2017
- Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.. 11. 2016
- Near-Infrared Intraoperative Chemiluminescence Imaging.. 11. 2016
- Design and synthesis of a MAO-B-selectively activated prodrug based on MPTP: a mitochondria-targeting chemotherapeutic agent for treatment of human malignant gliomas.. 10. 2015
- Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors.. 10. 2014
- Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity.. 8. 2013
- Discovery of 2-(2-benzoxazoyl amino)-4-aryl-5-cyanopyrimidine as negative allosteric modulators (NAMs) of metabotropic glutamate receptor 5 (mGlu₅): from an artificial neural network virtual screen to an in vivo tool compound.. 7. 2012
- Discovery of a pharmacologically active antagonist of the two-pore-domain potassium channel K2P9.1 (TASK-3).. 7. 2011
- The legumain protease-activated auristatin prodrugs suppress tumor growth and metastasis without toxicity.. 6. 2011
- Synthesis, cytotoxicity, and insight into the mode of action of Re(CO)3 thymidine complexes.. 5. 2010
- Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptor.. 4. 2009
- Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy.. 3. 2008
- Molecular design and chemical synthesis of a highly potent epothilone.. 1. 2006
- Copper: An Intracellular Achilles' Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics. 2021
- Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer. 2021